Sanofi cuts 466 jobs, all ties to new CV research

Anicka Slachta | June 25, 2019 | Cardiovascular Business | Economics

French drugmaker Sanofi is cutting 466 jobs as part of an R&D “reshuffle” that will also put an end to the company’s new research efforts in cardiology, Reuters reports.

A spokesperson said on June 19 the reorganization of Sanofi’s R&D department will allow the company to concentrate its research efforts on cancer, immunology, rare diseases and vaccines. While that means Sanofi is putting a halt to any new research in cardiology, its existing CV research programs will remain intact.

The 466 job cuts will be implemented on a voluntary basis, according to Reuters. Right now, Sanofi employs 15,000 R&D workers worldwide.

Read the story below:

Sanofi plans 466 job cuts as part of R&D reshuffle

Anicka Slachta

After graduating from Indiana University-Bloomington with a bachelor’s in journalism, Anicka joined TriMed’s Chicago team in 2017 covering cardiology. Close to her heart is long-form journalism, Pilot G-2 pens, dark chocolate and her dog Harper Lee.

Around the web

Health Imaging

Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Sanofi cuts 466 jobs, all ties to new CV research

Related Content

Around the web